Delivery Order SPE2DB22D1202-SPE2DB24FUHX2
Award Date 11/28/23
Potential Completion Date 11/29/23
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,259.73, is for the delivery of oxcarbazepine 300 mg/5 ml suspension, a generic anticonvulsant medication, with a completion date of February 25, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract, valued at $3,268.33, is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of October 30, 2023 and was awarded on October 27, 2022. This contract is not...
- This federal contract award, valued at $2,066.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The contract has a firm fixed price and an ultimate completion date of August 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The $4,104.42 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- This federal contract award is for the delivery of Oxcarbazepine 300 mg/5 ml Suspension, 250 ml to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,161.36, was awarded to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 26, 2024. It is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $1,702.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. It is a Firm Fixed Price Delivery Order, with an ultimate completion date of August 16, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp has significant experience providing a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,481.62 firm fixed-price delivery order is for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567260047 - Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The contract has a ceiling value of $1,364.06 and runs through February 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
- The Defense Logistics Agency awarded a $5,033.86 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Oxcarbazepine 300 mg/5 ml Suspension in a 250 ml quantity. This is a firm fixed-price contract with an ultimate completion date of January 13, 2026, with performance to be conducted in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,293.61 Firm Fixed Price Delivery Order covers the supply of 4,561,172,515 units of Oxcarbazepine 300 mg Tablets in 100-count bottles, with a completion date of June 8, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a substantial Indefinite Delivery...